Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Longitudinal bilateral parotid delta-radiomic kinetics and variance signatures for prediction of late xerostomia following radiotherapy.

Created on 13 Nov 2026

Authors

Damilola Oluwafemi Samson, Mahayu Ismail, Mohd Ariff Mohamed Hanifa, Eznal Izwadi Mohd Mahidin, Hanani Abdul Manan, Noorazrul Yahya

Published in

BMC medical imaging. Volume 26. Issue 1. Jul 09, 2026. Epub Jul 09, 2026.

Abstract

Radiation-induced xerostomia remains a significant concern in head-and-neck cancer radiotherapy, inadequately predicted, with unidentified kinetic signatures of parotid injury. This study aimed to identify predictive metrics and reproducible bilateral parotid delta-radiomic kinetics and variance features for late xerostomia.
This retrospective study included 131 HNC patients treated with VMAT-based radiochemotherapy. Weekly CBCT images (weeks 1-7) were collected (2020-2023). Twelve-month xerostomia was graded using CTCAE v5.0. IBSI-compliant bilateral parotid radiomics were extracted and converted to delta-radiomic kinetics. Patient-level data were split (training n: 91; testing n: 40), and feature selection combined univariate filtering with recursive feature elimination. Machine-learning models with stratified 5-fold cross-validation integrated clinical-dosimetric (CD), clinical-dosimetric + delta-radiomic (CDR), and clinical-dosimetric + delta-radiomic + kinetics (CDRK). Performance was evaluated using AUC (95% CI) and other metrics, with SHAP interpretability. Reliability (ICC, CCC, R2), multicollinearity, and bilateral asymmetry were assessed.
The prevalence of 12-month grade ≥ 2 xerostomia was nearly identical between cohorts (76.9%, 77.5%; SMD: 0.014), with no significant difference observed. Predictive performance enhanced with feature incorporation and peaked mid-treatment. Clinical-dosimetric models demonstrated limited early discrimination (AUC 0.38-0.45). Delta-radiomics improved performance at week-3, while combined kinetic models achieved optimal predictive performance at week-4 (SVM-CDRK AUC 0.81, p: 0.002, sensitivity 100%, specificity 86%, Brier score 0.06, F1-score 91%). LASSO- and MLP-CDRK yielded AUCs of 0.75 (p: 0.009) and 0.73 (p: 0.011) and F1-score (86%; 79%). Texture-based GLCM features (AUC 0.79, p: 0.003) outperformed first-order and morphological descriptors. Snorm-, AUClc-, and variance-based kinetics showed high longitudinal reliability (ICC/CCC > 0.86; R2 0.78-0.83), revealing week-4 as a potentially informative treatment phase.
Longitudinal bilateral parotid delta-radiomic kinetics significantly enhance late xerostomia prediction, identify mid-treatment as the optimal risk-stratification window, and support adaptive radiotherapy and personalized toxicity mitigation.

PMID:
42426645
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement